Histopathological prognostic factors in early breast carcinoma: an evaluation of cell proliferation in carcinoma cells

Bibliography

• Westenend PJ, Meurs CJ, Damhuis RA. Tumour size and vascular invasion predict distant metastasis in stage I breast cancer. Grade distinguishes early and late metastasis. J Clin Pathol 2005;58:196-201
   PubMed Web of Science ®Google Scholar
• Joensuu H, Pylkkanen L, Toikkanen S. Late mortality from pT1N0M0 breast carcinoma. Cancer 1999;85:2183-9
   PubMed Web of Science ®Google Scholar
• Moon TE, Jones SE, Bonadonna G, Development and use of a natural history data base of breast cancer studies. Am J Clin Oncol 1987;10:396-403
   PubMed Web of Science ®Google Scholar
• Neville AM, Bettelheim R, Gelber RD, Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The international (Ludwig) breast cancer study group. J Clin Oncol 1992;10:696-705
   PubMed Web of Science ®Google Scholar
• Quiet CA, Ferguson DJ, Weichselbaum RR, Natural history of node- negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol 1995;13:1144-51
   PubMed Web of Science ®Google Scholar
• Frkovic-Grazio S, Bracko M. Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma. J Clin Pathol 2002;55:88-92
   PubMed Web of Science ®Google Scholar
• Schootman M, Jeffe D, Reschke A, The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States. Breast Cancer Res Treat 2004;85:219-22
   PubMed Web of Science ®Google Scholar
• Hanrahan EO, Valero V, Gonzalez-Angulo AM, Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature. J Clin Oncol 2006;24:2113-22
   PubMed Web of Science ®Google Scholar
• Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol 2007;25:4952-60
   PubMed Web of Science ®Google Scholar
• Hewitt SM, Lewis FA, Cao Y, Tissue handling and specimen preparation in surgical pathology: issues concerning the recovery of nucleic acids from formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med 2008;132:1929-35
   PubMed Web of Science ®Google Scholar
• Horst KC, Smitt MC, Goffinet DR, Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer 2005;5:425-38
   PubMedGoogle Scholar
• Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957;11:359-77
   PubMed Web of Science ®Google Scholar
• Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10
   PubMed Web of Science ®Google Scholar
• Rosen PP, Groshen S. Factors influencing survival and prognosis in early breast carcinoma (T1N0M0–T1N1M0). Assessment of 644 patients with median follow-up of 18 years. Surg Clin North Am 1990;70:937-62
   PubMed Web of Science ®Google Scholar
• Nealon TFJ, Nkongho A, Grossi C, Pathologic identification of poor prognosis stage I (T1N0M0) cancer of the breast. Ann Surg 1979;190:129-32
   PubMed Web of Science ®Google Scholar
• Bilik R, Mor C, Wolloch Y, Histopathologic high risk factors influencing the prognosis of patients with early breast cancer (T1N0M0). Am J Surg 1986;151:460-4
   PubMed Web of Science ®Google Scholar
• Rauschecker HF, Sauerbrei W, Gatzemeier W, Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German breast cancer study group (GBSG). Eur J Cancer 1998;34:315-23
   PubMed Web of Science ®Google Scholar
• Boiesen P, Bendahl PO, Anagnostaki L, Histologic grading in breast cancer—reproducibility between seven pathologic departments. South Sweden breast cancer group. Acta Oncol 2000;39:41-5
   PubMed Web of Science ®Google Scholar
• Frierson HFJ, Wolber RA, Berean KW, Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 1995;103:195-8
   PubMed Web of Science ®Google Scholar
• Start RD, Flynn MS, Cross SS, Is the grading of breast carcinomas affected by a delay in fixation? Virchows Arch A Pathol Anat Histopathol 1991;419:475-7
   PubMedGoogle Scholar
• Bergers E, Jannink I, van Diest PI, The influence of fixation delay on mitotic activity and flow cytometric cell cycle variables. Hum Pathol 1997;28:95-100
   PubMed Web of Science ®Google Scholar
• de Azambuja E, Cardoso F, de Castro G Jr, Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer 2007;96:1504-13
   PubMed Web of Science ®Google Scholar
• Stuart-Harris R, Caldas C, Pinder SE, Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast 2008;17:323-34
   PubMed Web of Science ®Google Scholar
• Beresford MJ, Wilson GD, Makris A. Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Res 2006;8:216
   PubMed Web of Science ®Google Scholar
• Harris L, Fritsche H, Mennel R, American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. Am Soc Clin Oncol 2007;25:5287-312
   PubMed Web of Science ®Google Scholar
• Spyratos F, Ferrero-Pous M, Trassard M, Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value. Cancer 2002;94:2151-9
   PubMed Web of Science ®Google Scholar
• González-Vela MC, Garijo MF, Fernández F, MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors. Histol Histopathol 2001;16:399-406
   PubMed Web of Science ®Google Scholar
• Caly M, Genin P, Ghuzlan A, Analysis of correlation between mitotic index, MIB1 score and S-phase fraction as proliferation markers in invasive breast carcinoma. Methodological aspects and prognostic value in a series of 257 cases. Anticancer Res 2004;24:3283-8
   PubMed Web of Science ®Google Scholar
• Lynch BJ, Guinee DG Jr, Holden JA. Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer. Hum Pathol 1997;28:1180-8
   PubMed Web of Science ®Google Scholar
• Ahlin C, Aaltonen K, Amini R-M, Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values? Histopathology 2007;51:491-8
   PubMed Web of Science ®Google Scholar
• Colozza M, Azambuja E, Cardoso F, Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? Rev Ann Oncol 2005;16:1723-7
   PubMed Web of Science ®Google Scholar
• van Diest PJ, van der Wall E, Baak JP. Prognostic value of proliferation in invasive breast cancer: a review. J Clin Pathol 2004;57:675-81
   PubMed Web of Science ®Google Scholar
• Gerdes J, Lemke H, Baisch H, Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5
   PubMed Web of Science ®Google Scholar
• Mirza AN, Mirza NQ, Vlastos G, Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years. Ann Surg 2002;235:10-26
   PubMed Web of Science ®Google Scholar
• Weidner N, Moore DH II, Vartanian R. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel ‘paraffin’-reactive MIB1 antibody. Hum Pathol 1994;25:337-42
   PubMed Web of Science ®Google Scholar
• Pinto AE, Andre S, Pereira T, Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma. J Clin Pathol 2001;54:543-9
   PubMed Web of Science ®Google Scholar
• Sasano H, Anderson TJ, Silverberg SG, The validation of new aromatase monoclonal antibodies for immunohistochemistry-A correlation with biochemical activities in 46 cases of breast cancer. J Steroid Biochem Mol Biol 2005;95:35-9
   PubMed Web of Science ®Google Scholar